Examining the Complex Mismatch Negativity in Early Phase Psychosis
Author Information
Author(s): Bissonnette Jenna N., Anderson T-Jay, Crocker Candice E., Tibbo Philip G., Salisbury Dean F., Fisher Derek J.
Primary Institution: Dalhousie University
Hypothesis
The study hypothesizes that the complex mismatch negativity (cMMN) will provide a more sensitive marker of illness vulnerability in early phase psychosis compared to traditional measures.
Conclusion
The study found that individuals with early phase psychosis exhibited significantly reduced cMMN amplitudes, suggesting that the dual rule cMMN paradigm may effectively capture subtle neurofunctional changes in this population.
Supporting Evidence
- Reductions of cMMN amplitudes were found in individuals with early phase psychosis compared to healthy controls.
- The dual rule cMMN paradigm captures more subtle neurofunctional changes in early stages of psychosis.
- Significant differences in cMMN amplitudes were observed at the frontal electrode sites.
Takeaway
This study looked at how well a new test can find problems in the brain of people who are just starting to have serious mental health issues. It found that the test works better than older ones.
Methodology
The study used electroencephalography (EEG) to measure cMMN in 14 individuals with early phase psychosis and 15 healthy controls using a novel dual rule paradigm.
Potential Biases
Potential bias due to reliance on self-reported retrospective measures of substance use.
Limitations
The sample size was modest, and self-reported measures of substance use may be sensitive to bias.
Participant Demographics
14 individuals with early phase psychosis (9 males, 5 females) aged 20-26 and 15 healthy controls (4 males, 11 females) aged 18-26.
Statistical Information
P-Value
0.017
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website